Lobbying activity

Q2

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

LUNDBECK LLC for LUNDBECK LLC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q2

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income

Health Issues

View → Q2

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income

Medicare/Medicaid

View → Q2

LMH STRATEGIC SOLUTIONS for ALKERMES, INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues, Budget/Appropriations

View → Q1

ALSTON & BIRD LLP for TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income

Pharmacy, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q1

EMD SERONO, INC. for EMD SERONO INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Pharmacy, Veterans, Health Issues, Medicare/Medicaid

View → Q1

BIOGEN for BIOGEN

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Pharmacy, Taxation/Internal Revenue Code

View → Q1

AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Insurance, Pharmacy

View → Q1

DAIICHI SANKYO, INC. for DAIICHI SANKYO INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Copyright/Patent/Trademark

View → Q1

TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $70,000.00 income

Health Issues, Medicare/Medicaid, Budget/Appropriations

View → Q1

JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Pharmacy

View → Q1

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q1

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q1

INCYTE CORPORATION for INCYTE CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate

Medicare/Medicaid

View → Q1

TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

CHRONIC CARE POLICY ALLIANCE for CHRONIC CARE POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues

View → Q1

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q1

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View →